David B. Sykes - Publications

Siglec-15 is a glyco-immune checkpoint in prostate cancer regulating immune evasion and metastasis.

Journal: bioRxiv : the preprint server for biology

Published: August 20, 2026

Monoclonal gammopathy of clinical significance: a guide for nephrologists.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: August 03, 2026

Neutrophil degranulation and extracellular ROS production are inactivated by Yersinia pseudotuberculosis YopE through a SKAP2 independent pathway.

Journal: bioRxiv : the preprint server for biology

Published: June 12, 2026

Shifting IRES versus Cap-initiated translation during homeostatic stem cell differentiation and stress.

Journal: Science advances

Published: May 22, 2026

How I treat autoimmune neutropenia in adults.

Journal: Blood

Published: March 11, 2026

A new mouse model of thrombopoietin deficiency arising from a spontaneous single base pair mutation.

Journal: Platelets

Published: December 29, 2025

Targeting Siglec-engaging immunosuppressive sialoglycans to suppress prostate cancer bone metastasis.

Journal: British journal of cancer

Published: November 26, 2025

Differentiation stage-specific use of cap-independent and cap-dependent translation initiation in hematopoiesis.

Journal: bioRxiv : the preprint server for biology

Published: October 03, 2025

Multiomic analysis of clonal development reveals new regulators of leukemic cell growth.

Journal: Genes & development

Published: July 18, 2025

CCL3 is produced by aged neutrophils across cancers and promotes tumor growth.

Journal: Cancer cell

Published: July 09, 2025

Tracking NF-kB activity across steady-state neutrophil maturation.

Journal: Cell death discovery

Published: May 13, 2025

Optimal ex vivo production of functional neutrophils is dependent on the source of CD34+ human hematopoietic progenitors.

Journal: Experimental hematology

Published: March 10, 2025